Recon: Novo Nordisk launches Wegovy pill in US; Sanofi claims FDA will review diabetes drug age range

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States